Argenx
ARGX
#555
Rank
S$49.36 B
Marketcap
$784.53
Share price
2.91%
Change (1 day)
46.19%
Change (1 year)
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.

Earnings for Argenx (ARGX)

Earnings in 2024 (TTM): S$0.10 Billion

According to Argenx 's latest financial reports the company's current earnings are S$2.19 Billion. , an increase over its 2023 earnings that were of -S$0.41 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Argenx from 2013 to 2024

Annual earnings

Year Earnings Change
2024 S$0.11 B-127.97%
2023 -S$0.41 Billion-58.25%
2022 -S$0.99 Billion
2019 -S$0.27 Billion124.95%
2018 -S$0.12 Billion132.04%
2017 -S$51.27 Million54.86%
2016 -S$33.11 Million33%
2015 -S$24.9 Million13.63%
2014 -S$21.91 Million46.25%
2013 -S$14.98 Million